M&A Deal Summary

Endologix Acquires Nellix

On October 27, 2010, Endologix acquired medical products company Nellix from EW Healthcare Partners for 15M USD

Acquisition Highlights
  • This is Endologix’s 1st transaction in the Medical Products sector.
  • This is Endologix’s largest (disclosed) transaction.
  • This is Endologix’s 1st transaction in the United States.
  • This is Endologix’s 1st transaction in California.

M&A Deal Summary
Date 2010-10-27
Target Nellix
Sector Medical Products
Buyer(s) Endologix
Sellers(s) EW Healthcare Partners
Deal Type Add-on Acquisition
Deal Value 15M USD

Target

Nellix

Palo Alto, California, United States
Nellix, Inc. develops novel solutions for vascular disease

Search 198,123 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Endologix

Irvine, California, United States
Category Company
Founded 1992
Sector Medical Products
Revenue 156M USD (2018)
DESCRIPTION

Endologix is a medical device company dedicated to improving patients’ lives by providing innovative therapies for the interventional treatment of vascular disease. Endologix was founded in 1992 and is based in Irvine, California.

DEAL STATS #
Overall 1 of 2
Sector (Medical Products) 1 of 2
Type (Add-on Acquisition) 1 of 2
State (California) 1 of 2
Country (United States) 1 of 2
Year (2010) 1 of 1
Size (of disclosed) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-04-13 PQ Bypass

Milpitas, California, United States

PQ Bypass is a medical device pioneer bringing new advancements to the treatment of advanced peripheral artery disease (PAD). PQ Bypass devices are built upon nearly a decade of research and patented technological advancement. PQ Bypass was founded in 2009 and is based in Milpitas, California.

Buy -

Seller(S) 1

SELLER

EW Healthcare Partners

Investor Investor Investor Investor Investor

Category Growth Capital Firm
Founded 1985
PE ASSETS 3.0B USD
Size Large
Type Sector Focused
DESCRIPTION

Essex Woodlands Health Ventures is a growth equity and venture capital specialist investment firm focused on opportunities across the healthcare sector. Specific areas of interest include biotechnology, pharmaceuticals, medical devices, and healthcare services/IT. Historically, Essex invested primarily in early and later-stage situations; however, today the firm also makes growth capital investments between $20 - $60 million in companies valued between $50 - $250 million, as well as private investments in public entities (PIPEs). Essex Woodlands was formed in 1985 and offices in Palo Alto, California; New York City; Houston, Texas; Shanghai and London.

DEAL STATS #
Overall 21 of 52
Sector (Medical Products) 11 of 23
Type (Add-on Acquisition) 13 of 34
State (California) 8 of 16
Country (United States) 18 of 45
Year (2010) 6 of 7
Size (of disclosed) 22 of 22
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-10-27 Endologix

Irvine, California, United States

Endologix is a medical device company dedicated to improving patients’ lives by providing innovative therapies for the interventional treatment of vascular disease. Endologix was founded in 1992 and is based in Irvine, California.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-11-11 Complete Genomics

Mountain View, California, United States

Complete Genomics, Inc.develops complete human genome sequencing and analysis

Sell -
Mergr

Product

Company

Legal